Antigen Discovery Inc.

press release 6

admin — Wed, 25 Jan 2012 21:19:45 +0000

ADi’s technology selected by the SBRI and Bill & Melinda Gates Foundation to fight Malaria

Do you offer training on the use of your products?

admin — Tue, 16 Aug 2011 16:25:40 +0000

There is free training available at ADi headquarters in Irvine, CA. You are responsible for your travel arrangements. Please contact us in advance to schedule your visit. There is also an option to have ADi staff come to your facility … Continue reading →

press release 3

admin — Thu, 28 Jul 2011 10:20:31 +0000

ADi is awarded grant for Chlamydia Vaccine Development

press release 2

admin — Thu, 28 Jul 2011 10:18:04 +0000

Antigen Discovery, Inc. and Juvaris BioTherapeutics Form Strategic Collaboration

press release 1

admin — Thu, 28 Jul 2011 10:16:46 +0000

ADI/ImmPORT Awarded a SBIR Phase II to Commercialize Novel Antigens for Serodiagnostic Products and Vaccine Development

press releases 4

admin — Thu, 28 Jul 2011 10:14:49 +0000

ImmPORT’s Proteome Chip Technology Helps Identify Safer Smallpox Vaccine

press releases 5

admin — Thu, 28 Jul 2011 09:50:37 +0000

ImmPORT, FIND, and PHRI Announce Collaboration to Develop Critical Diagnostic Reagents for Tuberculosis

Peter J. Coassin

admin — Thu, 07 Jul 2011 14:14:34 +0000

Mr. Coassin has over 27 years of experience in the invention, development and commercialization of various life science innovations and holds 38 issued patents in technology with numerous applications pending. Inventions include: Instrumentation and methods for automated peptide synthesis; DNA synthesis methods, including the synthesis of DNA arrays for human diagnostics and a new cyclo olefin microplate technology. Mr. Coassin held senior scientist and management positions at Milligen, Millipore, Beckman Coulter, Aurora Biosciences and Vertex Pharmaceuticals. Mr. Coassin graduated from Tufts University with Bachelor of Science degrees in Chemistry and Biology.

Cynthia K. French, Ph.D., MBA

admin — Thu, 07 Jul 2011 14:12:24 +0000

Dr. French has a broad background as a scientific, technical, and business strategist with more than 15 years of proven performance in life science, in vitro diagnostics, and biotechnology. Dr. French has recently held the position of Vice President of Affymetrix’s clinical service laboratory business and laboratory research program. Dr. French has led research and product development programs at Quest Diagnostics, Bio-Rad Laboratories, Diagnostic Products Corporation, Reprogen and DuPont, focusing on commercialization of molecular and immuno-based diagnostic products and services. Dr. French received a Ph.D. in molecular biology and biochemistry and an MBA from the University of California, Irvine and conducted Postdoctoralwork in molecular genetics and vaccine development at the Massachusetts Institute of Technology and Harvard University.

Scott Weiss

admin — Thu, 07 Jul 2011 14:10:50 +0000

Mr. Weiss joined Antigen Discovery, Inc. (ADI) to direct the expansion and management of its medical device and service businesses. He has a broad business experience in the diagnostics and life science industry. As an innovative leader with 15+ years of sales and marketing experience, he has a proven track record of building teams to deliver business critical results. Mr. Weiss came to ADI from Cellestis, Inc. where he served as a Vice President of Sales and he built sales, technical, and customer service teams. Prior to that from 1990 to 2005, Mr. Weiss held various sales and marketing positions at Dupont, Irvine Scientific, and CliniQA. He finished his career at CliniQA as the Marketing Manager. Mr. Weiss earned his B.S. in Business Administration from the University of Northern Colorado.